Melissa Hanna-Brown | |
---|---|
Alma mater |
King's College London University of Sunderland |
Scientific career | |
Institutions |
Pfizer UK King's College London University of Warwick |
Website |
kclpure |
Melissa Hanna-Brown is a British pharmacologist. She works for Pfizer UK and is a visiting professor at the University of Warwick.
Hannah-Brown became interested in pharmacy as a child, when she worked at her local chemists on the weekend. [1] She studied Pharmaceutical Science at the University of Sunderland, spending a year at GlaxoSmithKline and graduating in 1995. [2] She completed a Biotechnology and Biological Sciences Research Council (BBSRC) SmithKline Beecham sponsored PhD in pharmaceutical analysis at King's College London in 1998. [2] [3]
Hannah-Brown remained at King's College London as an Engineering and Physical Sciences Research Council (EPSRC) funded postdoctoral researcher. [2] She became a lecturer in the Department of Pharmacy in 2000. [2] She won the Desty Memorial Prize for Contribution to Separation Science in 2000. [4] She developed instrumentation to enable detection of trace components in biofluids supported by Research Councils UK. [5] [6]
In 2006 Hanna-Brown was appointed as Separation Science Lead at Pfizer UK, and made head of the Analytical Team in 2008. [2] She was made visiting full professor at the University of Warwick in 2011. [2] In 2014 she was appointed Technology & Innovation Lead for the Pfizer Worldwide R&D division. [2] She works on drug analytical science to support the development of drugs to applications. [4] Her work looks at analytical quality. [7] She also looks at using Quality by Design to develop chromatographic methods. [8]
She was the President of the Royal Society of Chemistry (RSC) analytical division council in 2017 and is Vice Chair of the separation science group. [4] [9] [7] Hanna-Brown contributes to diversity and inclusion initiatives at Pfizer, writing their gender pay gap report. [10]
Hanna-Brown was included in the Top 30 Women Leaders in the UK in 2018. [11]
Melissa Hanna-Brown | |
---|---|
Alma mater |
King's College London University of Sunderland |
Scientific career | |
Institutions |
Pfizer UK King's College London University of Warwick |
Website |
kclpure |
Melissa Hanna-Brown is a British pharmacologist. She works for Pfizer UK and is a visiting professor at the University of Warwick.
Hannah-Brown became interested in pharmacy as a child, when she worked at her local chemists on the weekend. [1] She studied Pharmaceutical Science at the University of Sunderland, spending a year at GlaxoSmithKline and graduating in 1995. [2] She completed a Biotechnology and Biological Sciences Research Council (BBSRC) SmithKline Beecham sponsored PhD in pharmaceutical analysis at King's College London in 1998. [2] [3]
Hannah-Brown remained at King's College London as an Engineering and Physical Sciences Research Council (EPSRC) funded postdoctoral researcher. [2] She became a lecturer in the Department of Pharmacy in 2000. [2] She won the Desty Memorial Prize for Contribution to Separation Science in 2000. [4] She developed instrumentation to enable detection of trace components in biofluids supported by Research Councils UK. [5] [6]
In 2006 Hanna-Brown was appointed as Separation Science Lead at Pfizer UK, and made head of the Analytical Team in 2008. [2] She was made visiting full professor at the University of Warwick in 2011. [2] In 2014 she was appointed Technology & Innovation Lead for the Pfizer Worldwide R&D division. [2] She works on drug analytical science to support the development of drugs to applications. [4] Her work looks at analytical quality. [7] She also looks at using Quality by Design to develop chromatographic methods. [8]
She was the President of the Royal Society of Chemistry (RSC) analytical division council in 2017 and is Vice Chair of the separation science group. [4] [9] [7] Hanna-Brown contributes to diversity and inclusion initiatives at Pfizer, writing their gender pay gap report. [10]
Hanna-Brown was included in the Top 30 Women Leaders in the UK in 2018. [11]